Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Century Therapeutics (IPSC) Times Interest Earned (2022 - 2023)

Historic Times Interest Earned for Century Therapeutics (IPSC) over the last 2 years, with Q2 2023 value amounting to -$257.92.

  • Century Therapeutics' Times Interest Earned fell 17148.51% to -$257.92 in Q2 2023 from the same period last year, while for Mar 2024 it was -$1071.9, marking a year-over-year decrease of 116812.7%. This contributed to the annual value of -$271.38 for FY2023, which is 18997.43% down from last year.
  • Per Century Therapeutics' latest filing, its Times Interest Earned stood at -$257.92 for Q2 2023, which was down 17148.51% from -$79.41 recorded in Q1 2023.
  • Century Therapeutics' Times Interest Earned's 5-year high stood at -$79.41 during Q1 2023, with a 5-year trough of -$257.92 in Q2 2023.